# Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes

> **Open Intelligence Dossier** · First detected: 2026-09-23 01:20 UTC · Category: Business

## Executive Summary
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes&quot; is generating significant coverage in the Business category, with 2 articles from 2 distinct sources tracked by PULSE so far.


Outlets currently covering the story include qz.com and Yahoo. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| qz.com | Roche obesity and diabetes drug enicepatide Phase 2 trial results | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxPeUR0WHE4OHA1dF9NMXBMZklLOUFuelNteWI2TFZXMmFsWElHcXJVVW5xX05FQVNHSGlkeTJNWnJvbVdXeFlXYUljemgweTMxZTdUVzNnajVzQU90ZHZLSnoxVW9mN0g3TkZEWFdJblFsbG84Yk1Pem9SRFpnVGxOejdvSzU?oc=5) |
| Yahoo | Roche’s acquired GLP-1/GIP normalises blood sugar in Phase II trial | [Source Link](https://news.google.com/rss/articles/CBMiiwFBVV95cUxPWjNORjl4T2RjcDhTSll0OGhPMmJrZUhBRkFpaVA4OXg3aTJfTERYWmJfUVBUbVBlakIycFlpMllIek9WTEpwQWtVcURaOWQ1OFhsbXdxNzJfXzdXZktkNlV3OWkyaFFmWW4zMHZXQ05lTktJdjVnNTl0NkVEVHRCYWlNakJFU1o4M2JR?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-09-23/roche-s-glp-1-gip-drug-hits-in-phase-2-diabetes-trial-fueling-best-in-disease*
